B
The startup develops diagnostic devices that differentiate between bacterial and viral infections in patients presenting cold symptoms. This rapid identification enables physicians to prescribe the appropriate treatment immediately, reducing unnecessary antibiotic use and shortening recovery times.
Bellevue, United States
Updated 2 months ago
Funding
$10.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops diagnostic devices that differentiate between bacterial and viral infections in patients presenting cold symptoms. This rapid identification enables physicians to prescribe the appropriate treatment immediately, reducing unnecessary antibiotic use and shortening recovery times.